A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment BNT327 and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
BioNTech SE
BioNTech SE
Eli Lilly and Company
BigHat Biosciences, Inc.
St. Jude Children's Research Hospital
Parabilis Medicines, Inc.
Cancer Research UK
Lumos Pharma
Turning Point Therapeutics, Inc.
Recurv Pharma Inc
iOnctura
Eisai Inc.
GlaxoSmithKline
St. Jude Children's Research Hospital
NeoImmuneTech
Sichuan Enray Pharmaceutical Sciences Company
Lokon Pharma AB
A2 Biotherapeutics Inc.
Essen Biotech
Essen Biotech
Nouscom SRL
Revolution Medicines, Inc.
DualityBio Inc.
Grey Wolf Therapeutics
M.D. Anderson Cancer Center
Ocellaris Pharma, Inc.
Eli Lilly and Company
Inhibrx Biosciences, Inc
Tyligand Pharmaceuticals (Suzhou) Limited
GV20 Therapeutics
Mirati Therapeutics Inc.
Genfleet Therapeutics (Shanghai) Inc.
National University Hospital, Singapore
A2 Biotherapeutics Inc.
Palleon Pharmaceuticals, Inc.
Sensei Biotherapeutics, Inc.
NuCana plc
Yonsei University
PharmaMar
Medicenna Therapeutics, Inc.
Marengo Therapeutics, Inc.
Cancer Research UK
Hoffmann-La Roche
Numab Therapeutics AG
Thomas Jefferson University
Thomas Jefferson University
Esperas Pharma Inc.
AtlasMedx, Incorporated
A2 Biotherapeutics Inc.
Xynomic Pharmaceuticals, Inc.
Intensity Therapeutics, Inc.